For the year ending 2025-12-31, TVGN has $4,382,994 in assets. $12,617,720 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 552,372 | |||
| Prepaid expenses and other assets | 828,592 | |||
| Due from related party | 158,819 | |||
| Total current assets | 1,539,783 | |||
| Property and equipment, gross | 584,837 | |||
| Less accumulated depreciation | 414,529 | |||
| Property and equipment, net | 170,308 | |||
| Right-of-use assets - operating leases | 1,423,473 | |||
| Deferred transaction costs | 183,546 | |||
| Other assets | 1,065,884 | |||
| Total assets | 4,382,994 | |||
| Accounts payable | 3,340,127 | |||
| Accrued expenses and other liabilities | 1,499,624 | |||
| Operating lease liabilities | 327,740 | |||
| Notes payable | 1,651,000 | |||
| Due to related party | 250,000 | |||
| Total current liabilities | 7,068,491 | |||
| Loan agreement | 4,400,000 | |||
| Operating lease liabilities | 1,122,750 | |||
| Derivative warrant liabilities | 26,479 | |||
| Total liabilities | 12,617,720 | |||
| Preferred stock, value-Series APreferred Stock | 2,799,990 | |||
| Preferred stock, value-Series CPreferred Stock | 6,000,000 | |||
| Common stock, 0.0001 par value 800,000,000 shares authorized 4,020,746 and 3,559,827 shares issued and outstanding at december 31, 2025 | 402 | |||
| Additional paid-in capital | 122,625,431 | |||
| Accumulated deficit | -139,660,549 | |||
| Total stockholders deficit | -8,234,726 | |||
| Total liabilities and stockholders deficit | 4,382,994 | |||
Tevogen Bio Holdings Inc. (TVGN)
Tevogen Bio Holdings Inc. (TVGN)